Nell Greenfieldboyce, NPR, July 21, 2014
To do a better job of spotting unforeseen risks and side effects, the FDA is trying something new. It’s called Mini-Sentinel, and it’s a $116 million government project to actively go out and look for adverse events linked to marketed drugs. This pilot program is able to mine huge databases of medical records for signs that drugs may be linked to problems. […read more]